Home > Insider Trading > Filing (0001209191-20-031059)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
353569	Quidel Corp	QDEL	In Vitro & In Vivo Diagnostic Substances (2835)	942573850

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1631320	Jr. Donald Michael Abney	9975 Summers Ridge Road San Diego CA 92121	Svp - Distribution	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-05-18	8,798	$15.40	15,432	No	4	M	Direct
Common Stock	Disposition	2020-05-18	8,798	$198.12	6,634	No	4	S	Direct
Common Stock	Acquisiton	2020-05-18	7,172	$21.08	13,806	No	4	M	Direct
Common Stock	Disposition	2020-05-18	7,172	$198.87	6,634	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option	Disposition	2020-05-18	8,798	$0.00	8,798	$15.40
Common Stock	Non-Qualified Stock Option	Disposition	2020-05-18	7,172	$0.00	7,172	$21.08

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2026-02-10	No	4	M	Direct
7,171		2027-02-15	No	4	M	Direct

Footnotes

The weighted average sale price for these transactions was $198.1224 per share, with a range of $193.13 to $201.97. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.
The weighted average sale price for these transactions was $198.8715 per share, with a range of $196.035 to $201.97. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.
17,596 shares vested on the second anniversary date of the grant date, February 10, 2018. 8.798 shares vested on the third anniversary date of the grant date, February 10, 2019. 8,798 shares vested on the fourth anniversary date of the grant date, February 10, 2020.
7,172 shares vested on the second anniversary date of the grant date, February 15, 2019. 3,586 shares vested on the third anniversary date of the grant date, February 15, 2020. 3,585 shares will vest on the fourth anniversary date of the grant date, February 15, 2021.